Friday, July 26, 2024 1:02:15 PM
StonkMaster, personally, and IMHO, I believe the MTD should be denied, but nothing can be certain.
I’m throwing lots of weasel words to my comment because this is a fairly new type of claim/cause of action, perhaps not a case of first impression, but seems close, thus no deep caselaw jurisprudentially to rely on. So the court may be proceeding much more carefully and giving this a much higher level of scrutiny than it might for a more well-trod path sort of case.
Just a guess, but this may be, at least in part, why (to me) the bar seems so high here to file a complaint adequately stating a claim upon which relief may be granted, ie, eg, the standard to survive a 12(b)(6) MTD motion. I’m not even close to any sort of litigation expert, but never seen a requirement to plead facts with such specificity to survive a MTD, BEFORE discovery, to meet the well-plead complaint standard.
Lots of jibber-jabber re some of my background thoughts, to simply say IMHO I believe the MTD will be denied. Sorry about the meandering. Cap
I’m throwing lots of weasel words to my comment because this is a fairly new type of claim/cause of action, perhaps not a case of first impression, but seems close, thus no deep caselaw jurisprudentially to rely on. So the court may be proceeding much more carefully and giving this a much higher level of scrutiny than it might for a more well-trod path sort of case.
Just a guess, but this may be, at least in part, why (to me) the bar seems so high here to file a complaint adequately stating a claim upon which relief may be granted, ie, eg, the standard to survive a 12(b)(6) MTD motion. I’m not even close to any sort of litigation expert, but never seen a requirement to plead facts with such specificity to survive a MTD, BEFORE discovery, to meet the well-plead complaint standard.
Lots of jibber-jabber re some of my background thoughts, to simply say IMHO I believe the MTD will be denied. Sorry about the meandering. Cap
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
